Join
Live feed
·
INSIDERFilingvia Quantisnow
Blueprint Medicines Corporation logo

CHIEF SCIENTIFIC OFFICER Carter Percy H. sold $134,791 worth of shares (1,051 units at $128.25), decreasing direct ownership by 2% to 53,155 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
BPMC· Blueprint Medicines Corporation
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BPMC (Blueprint Medicines Corporation) and more on Quantisnow.